ChemicalBook
Chinese Japanese Germany

5-Fluorouracil

Antimetabolite Pharmacokinetics Indications Drug interaction Adverse reactions and precautions Fluorofur Chemical property Uses Methods of production
5-Fluorouracil
5-Fluorouracil
CAS No.
51-21-8
Chemical Name:
5-Fluorouracil
Synonyms
FU;Ulup;5-FU;Fluri;Arumel;Efudex;Efudix;Efurix;Fluril;U-8953
CBNumber:
CB8162744
Molecular Formula:
C4H3FN2O2
Formula Weight:
130.08
MOL File:
51-21-8.mol

5-Fluorouracil Properties

Melting point:
282-286 °C (dec.)(lit.)
Boiling point:
190-200°C/0.1mmHg
storage temp. 
Store at 0-5
solubility 
H2O: 10 mg/mL, clear
form 
powder
color 
white
PH
4.3-5.3 (10g/l, H2O, 20℃)
Water Solubility 
12.2 g/L 20 ºC
Sensitive 
Air Sensitive
Merck 
14,4181
BRN 
127172
Stability:
Stable. Light sensitive. Combustible. Incompatible with strong oxidizing agents, strong bases.
CAS DataBase Reference
51-21-8(CAS DataBase Reference)
NIST Chemistry Reference
2,4-Pyrimidinedione, 5-fluoro-(51-21-8)
EPA Substance Registry System
2,4(1H,3H)-Pyrimidinedione, 5-fluoro-(51-21-8)
SAFETY
  • Risk and Safety Statements
  • Hazard and Precautionary Statements (GHS)
Hazard Codes  Xn,T,C,Xi
Risk Statements  22-20/21/22-52-25
Safety Statements  36-36/37-36/37/39-22-45-26
RIDADR  UN 2811 6.1/PG 3
WGK Germany  3
RTECS  YR0350000
10-23
Hazard Note  Irritant/Highly Toxic
TSCA  T
HazardClass  6.1
PackingGroup  III
HS Code  29335995
Hazardous Substances Data 51-21-8(Hazardous Substances Data)
Symbol(GHS):
Signal word: Danger
Hazard statements:
Code Hazard statements Hazard class Category Signal word Pictogram P-Codes
H301 Toxic if swalloed Acute toxicity,oral Category 3 Danger P264, P270, P301+P310, P321, P330,P405, P501
H302 Harmful if swallowed Acute toxicity,oral Category 4 Warning P264, P270, P301+P312, P330, P501
H315 Causes skin irritation Skin corrosion/irritation Category 2 Warning P264, P280, P302+P352, P321,P332+P313, P362
H319 Causes serious eye irritation Serious eye damage/eye irritation Category 2A Warning P264, P280, P305+P351+P338,P337+P313P
H341 Suspected of causing genetic defects Germ cell mutagenicity Category 2 Warning P201,P202, P281, P308+P313, P405,P501
H351 Suspected of causing cancer Carcinogenicity Category 2 Warning P201, P202, P281, P308+P313, P405,P501
H360 May damage fertility or the unborn child Reproductive toxicity Category 1A, 1B Danger
H373 May cause damage to organs through prolonged or repeated exposure Specific target organ toxicity, repeated exposure Category 2 Warning P260, P314, P501
Precautionary statements:
P201 Obtain special instructions before use.
P260 Do not breathe dust/fume/gas/mist/vapours/spray.
P264 Wash hands thoroughly after handling.
P264 Wash skin thouroughly after handling.
P270 Do not eat, drink or smoke when using this product.
P280 Wear protective gloves/protective clothing/eye protection/face protection.
P405 Store locked up.
P501 Dispose of contents/container to..…

5-Fluorouracil price More Price(21)

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
Sigma-Aldrich 04541 5-Fluorouracil certified reference material, TraceCERT 51-21-8 50mg $132.5 2017-11-08 Buy
Sigma-Aldrich 03738 5-Fluorouracil analytical standard 51-21-8 100mg $47.7 2017-11-08 Buy
TCI Chemical F0151 5-Fluorouracil >99.0%(HPLC)(T) 51-21-8 5g $43 2017-11-08 Buy
TCI Chemical F0151 5-Fluorouracil >99.0%(HPLC)(T) 51-21-8 25g $131 2017-11-08 Buy
Alfa Aesar A13456 5-Fluorouracil, 99% 51-21-8 5g $45.5 2017-11-08 Buy

5-Fluorouracil Chemical Properties,Uses,Production

Antimetabolite

5-fluorouracil is short for fluorouracil, and is pyrimidine antimetabolites, 5-fluorouracil as fluorouracil for pyrimidine antimetabolites, is currently clinically commonly used a chemotherapy drug, having effect on proliferation, can prevent the thymine formation, inhibition of DNA biosynthesis, thereby inhibiting the growth of cancer cells. Clinically, it is used to treat gastrointestinal tumors, such as stomach cancer, colon cancer, liver cancer and so on. In breast cancer, ovarian cancer, lung cancer, bladder cancer, cervical cancer, pancreatic cancer and so on are also effective. The Swiss production of skin cancer treatment ointment containing 5% of the goods, mainly used for actinic keratoses and senile keratosis, precancerous dermatitis, single and multiple shallow table basal cell carcinoma, radioactive skin lesion of carcinoma and superficial basal cell carcinoma.
5-fluorouracil first changes for 5-Fluoro 2 deoxy urea pyrimidine nucleotides in vivo and inhibition of thymidylate synthase, blocking the transformation of urea pyrimidine deoxyribonucleotide thymidine, which affects DNA biosynthesis. At the same time, it can be incorporation into RNA by blocking urea ethyl pyridine and whey acid was incorporated into the RNA to direct inhibition of RNA synthesis.
This medicine is mainly in the liver metabolism, most of the decomposed into carbon dioxide discharged from breathing, rarely excreted from urine. After oral, absorption is different; vein after administration, concentrations in plasma quickly drop in two hours; static note within 30 minutes can arrive in cerebrospinal fluid (CSF) and maintain for 3 hours; continuous intravenous infusion toxicity is lighter than intravenous injection; vein to the drug's effect is compared with oral high. Toxicity of 5-fluorouracil on the proliferation is greater than non proliferating cells, but no obvious cell cycle specificity. Resistance to 5-FU can increase essential activity of enzyme missing or thymidylate synthetase activity.
The above information is edited by the Chemicalbook Hayan.

Pharmacokinetics

Due to the instability of the absorption of 5-fluorouracil, the conventional the oral (in Europe can be obtained from oral preparation). General intravenous administration, We can also take transarterial Administration in order to directly reach the tumor (e.g. liver metastasis through hepatic artery) and injected directly into the body cavity infiltration liquid (such as ovarian cancer). Intravenous injection plasma half-life is 7.5~10 minutes, after 3 hours the drug in the plasma has not check did not change. Intracellular drug levels are last much longer.
Fluorouracil in the liver is used for metabolism; 60~80% in 8~12 hours as a respiratory carbon dioxide discharge and 15% in 6 hours technical unchanged from the urine discharge. The drug can enter into the exudate and cerebrospinal fluid (CSF). It has existed determination method for plasma fluorouracil.

Indications

It is clinical for breast cancer, digestive tract cancer, ovarian cancer and primary bronchogenic lung adenocarcinoma adjuvant chemotherapy and palliative care; is also in the treatment of malignant hydatidiform mole, choriocarcinoma, serous cancer of effusion in bladder cancer and head and neck malignant tumor and liver cancer chemotherapy drugs.
Dermatological topical containing 5% 5-fluorouracil ointment is used in the treatment of actinic keratosis, actinic cheilitis, Bowen's disease, erythroplasia of Queyrat, Bowenoid papulosis, condyloma acuminatum, vitiligo, lichen amyloidosis, disseminated superficial porokeratosis, warts, flat warts, psoriasis, color of dry skin disease, superficial basal cell epithelioma table etc.; intralesional injection in the treatment of keratoacanthoma keloid.

Drug interaction

Before using this drug, first it is used methotrexate, 5-fluorouracil nucleotide formation is increased by increasing the content of intracellular phosphoribosyl pyrophosphate. Allopurinol can change the role of fluorouracil. Its metabolites, oxypurinol, can inhibit orotate phosphoribosyl transferase and thus reduce the toxicity and may improve the therapeutic index. Increase in thymidine and other nucleoside combination of fluorouracil and RNA and thymidine by dihydropyrimidine dehydrogenase can delay fluorouracil decomposition. However, the drug combination did not significantly improve the clinical effect so far.

Adverse reactions and precautions

The main toxic effect of fluorouracil is involving the gastrointestinal tract and blood cell generation system. Anorexia, nausea and vomiting were common. Stomatitis, pharyngo esophageal inflammation and diarrhea are withdrawal indication, otherwise there will be serious oropharyngeal and intestinal ulcers. Intravenous administration of gastrointestinal toxicity is often limiting dose. On the contrary, huge doses of intravenous injection, white cell reduction is the dose limiting toxicity. Low white cell counts often appear in medication for the first time after 7 to 14 days. Thrombocytopenia is not too obvious, appeared in 7~17. Monitoring of blood cell count is necessary.
Other adverse reactions are hair loss, dermatitis and pigment calm. There were acute and chronic conjunctivitis. Reversible cerebellar ataxia occurs in 1% of patients, possibly is related to the dose, occur at any time of the treatment process (often a few months later). After Cerebellar signs in the withdrawal can be last for a few of weeks. Myocardial ischemia occasionally appeared in the 5-FU intravenous drip. The drug in animals is caused by abnormal and may be carcinogenic.
Damage to the liver function of patients (e.g. extensive liver metastasis) fluorouracil should be reduced; The nutritional status of patients with poor medication should be cautious.
Using daily intermittent intravenous drip for 4~5d, can greatly reduce the toxic effects of blood. However, the results of clinical research mean rapid injection or intravenous drip method in the treatment of superiority. Long term intravenous drip infusion can be accompanied by pain, erythema and skin scaling of hand-foot comprehensive syndrome.
This medicine to FDA pregnancy category D.

Fluorofur

Fluorofur is fluorine urea pyrimidine derivatives, and effect is similar with fluorouracil, but chemotherapy index double higher than fluorouracil and toxicity is only the 1/4 to 1/6 of fluorouracil. It is suitable for gastrointestinal cancer and breast cancer. There are oral, intravenous and anal suppository three formulations.

Chemical property

It is white or white crystalline powder. Mp is 282-283℃ (decomposition), 0.1 mol/L hydrochloric acid solution has maximum absorption at 265nm wavelength. It is slightly soluble in water and ethanol, insoluble in chloroform and ether, soluble in dilute hydrochloric acid and sodium hydroxide solution. Medium toxicity, LD50 (mouse, i.p.) is 230mg/kg.

Uses

1. It is used for biochemical studies and antitumor drugs.
2. It is the anti tumor drug, also used for synthesis of flucytosine. 5-fluorouracil can be used in the study of rice in the biochemical studies, ear differentiation, genetic metabolic measurement, plant growth development research.
3. It is used for the digestive system cancer, head and neck cancer, gynecological cancer, lung cancer, liver cancer, treatment of bladder cancer and skin cancer.
4. Antimetabolite antitumor drugs.
5. Anti tumor drugs. There is a certain effect on a variety of tumors such as digestive tract cancer, breast cancer, ovarian cancer, chorionic epithelial cancer, cervical cancer, hepatocellular carcinoma, bladder cancer, skin cancer (topical), leukoplakia (topical) etc. Adverse reactions mainly are bone marrow transplantation, digestive tract reaction, serious person can have diarrhea, local injection site phlebitis, a few of which have nervous system reactions such as cerebellar degeneration and ataxia. The course of medication should strictly check the blood.

Methods of production

1. It is obtained by fluoride ethyl acetate by condensation, cyclization and hydrolysis.
(1). Condensation, cyclization. Sodium methoxide is input dry stainless steel reaction pot, stirring under vacuum concentration to sodium methoxide into white powder, cooling to 50℃, adding toluene, then cold to below 10℃, dropping ethyl formate. After adding remained below 10℃, dripping ethyl fluoroacetate. Completely, at about 30℃ stirring reaction for 8 hours. Static, obtain pale yellow thick mixture. In the condensation product, adding methanol and methyl isobutyl urea sulfate, stirring and heating to 66-70℃, reflux reaction for 6h. Atmospheric recovering methanol to the reaction material showing a thin paste, then vacuum distilled to viscous so far. Heating, dissolving in water, adding activated charcoal, filtered, and the filtrate with concentrated hydrochloric acid to pH3-4, crystallization, cooling and filtering, use cold water to wash the filter cake, using boiling water to regulate plasma immersion to recognize, filtering, water washing, drying, to 5-fluorouracil (-4-hydroxy-2-four oxygen pyrimidine C5H5FN2O2. (2). The hydrolysis of the cyclization product 5-Fluoro-4-hydroxy-2-methoxy pyrimidine and adding 20% hydrochloric acid in 60℃are hydrolysis for 4h, after processing to obtain 5-fluorouracil.
2. 2-methylthio-5-fluorouracil is under acidic conditions and reflux system to obtain 5-fluorouracil.

Chemical Properties

Crystalline

Uses

A potent antineoplastic agent in clinical use. Also an inhibitor of DNA synthesis

Uses

antineoplastic, pyrimidine antimetabolite

Uses

5-Fluoro Uracil is an active metabolite of Doxifluridine (D556750).

General Description

White to nearly white crystalline powder; practically odorless. Used as an anti neoplastic drug, chemosterilant for insects.

Air & Water Reactions

Insoluble in water.

Reactivity Profile

5-Fluorouracil may be sensitive to prolonged exposure to light. Solutions discolor on storage. 5-Fluorouracil can react with oxidizing agents and strong bases. Incompatible with methotrexate sodium.

Health Hazard

Minimum toxic dose in humans is approximately 450 mg/kg (total dose) over 30 days for the ingested drug. Intravenous minimum toxic dose in humans is a total dose of 6 mg/kg over three days. Depression of white blood cells occurred after intravenous administrative of a total dose of 480 mg/kg over 32 days. Occasional neuropathy and cardiac toxicity have been reported. Do not use during pregnancy. Patients with impaired hepatic or renal function, with a history of high-dose pelvic irradiation or previous use of alkylating agents should be treated with extreme caution. Patients with nutritional deficiencies and protein depletion have a reduced tolerance to 5-Fluorouracil.

Fire Hazard

Emits very toxic fumes of flourides and nitrogen oxides when heated to decomposition. Avoid decomposing heat.

Biological Activity

Anticancer agent. Metabolized to form fluorodeoxyuridine monophosphate (FdUMP), fluorodeoxyuridine triphosphate (FdUTP) and fluorouridine (FUTP). FdUMP inhibits thymidylate reductase causing a reduction in dTMP synthesis. FUTP and FdUTP are misincorporated into RNA and DNA respectively.

5-Fluorouracil Preparation Products And Raw materials

Raw materials

Preparation Products


5-Fluorouracil Suppliers

Global( 424)Suppliers
Supplier Tel Fax Email Country ProdList Advantage
Mainchem Co., Ltd.
0592-6210733
0592-6210733 sales@mainchem.com CHINA 1948 55
Shenzhen Sendi Biotechnology Co.Ltd.
0755-23311925 18102838259
0755-23311925 Abel@chembj.com CHINA 3229 55
Alfa Aesar 400-610-6006; 021-67582000
021-67582001/03/05 saleschina@alfa-asia.com China 30309 84
Dalian Meilun Biotech Co., Ltd. 0411-66771943;0411-66771942
0411-66771945 sales@meilune.com China 4801 58
China Synchem Technology Co.,Ltd. +86-552-4929304
+86-552-4928800 sales@cnsynchem.com China 51 65
Huainan Kedi Chemical Factory 0554-2106669
0554-2666215 sales1@kedichem.com China 5004 55
Wuhan HongxinKang Fine Chemical Co., Ltd. 027-59362599 18674037007
027-84802889 zhuoxingwc@163.com China 942 58
Jinan Aery Pharmaceutical Co,.Ltd 86-0531-81263406
86-0531-58591634 sales@aerpharm.com China 68 55
J & K SCIENTIFIC LTD. 400-666-7788 +86-10-82848833
+86-10-82849933 jkinfo@jkchemical.com;market6@jkchemical.com China 96820 76
Meryer (Shanghai) Chemical Technology Co., Ltd. +86-(0)21-61259100(Shanghai) +86-(0)755-86170099(ShenZhen) +86-(0)10-62670440(Beijing)
+86-(0)21-61259102(Shanghai) +86-(0)755-86170066(ShenZhen) +86-(0)10-88580358(Beijing) sh@meryer.com China 40398 62

51-21-8(5-Fluorouracil)Related Search:


Copyright 2017 © ChemicalBook. All rights reserved